VRIBOSE 0.3 TABLET
Generic Salt Composition: Voglibose 0.3mg
Price: ₹15 MRP: ₹91.88
Save up to 84% compared to branded medicines.
Top Brand Substitutes & Equivalents
Vobose 0.3, Volix 0.3, Voglitor 0.3, Voglistat 0.3, Glibose 0.3, Voglib 0.3, Vogo 0.3, Voglix 0.3, Vobose MD 0.3, Volibo 0.3, Voglitor MD 0.3, Voglinorm 0.3, Voglilife 0.3, Vogligen 0.3, Voglirex 0.3, Vogliz 0.3, Voglismart 0.3, Vogliday 0.3, Voglirise 0.3, Voglibose Sun Pharma, Sun Pharma Voglibose, Voglibose Cipla, Cipla Voglibose, Voglibose Dr Reddys, Dr Reddys Voglibose, Voglibose Lupin, Lupin Voglibose, Voglibose Torrent, Torrent Voglibose, Voglibose Alkem
Product Overview & Uses
VRIBOSE 0.3 TABLET is a potent alpha-glucosidase inhibitor specifically formulated for the management of glycemic control in individuals diagnosed with Type 2 Diabetes Mellitus. Falling under the essential Diabetes Care category, this medication functions by competitively and reversibly inhibiting alpha-glucosidase enzymes in the small intestine. By slowing the hydrolysis of complex carbohydrates into monosaccharides, VRIBOSE 0.3 TABLET effectively blunts the postprandial rise in blood glucose levels. Clinical evidence supports the use of VRIBOSE 0.3 TABLET as a monotherapy or in combination with other oral hypoglycemic agents like metformin or sulfonylureas. Patients are advised that VRIBOSE 0.3 TABLET should be taken immediately before the first bite of each main meal to ensure optimal enzymatic inhibition. Consistent monitoring of blood glucose is essential while on VRIBOSE 0.3 TABLET therapy to avoid hypoglycemia, especially when used in combination with other antidiabetic drugs. The therapeutic efficacy of VRIBOSE 0.3 TABLET is well-documented in reducing HbA1c levels and improving overall metabolic profiles in diabetic patients.